|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,306 JPY | -0.90% |
|
+0.57% | -8.33% |
| 04-30 | Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion | RE |
| 04-29 | US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week | MT |
April 29 (Reuters) - Deciphera Pharmaceuticals said on Monday Japan's Ono Pharmaceutical Co will acquire the cancer drug developer for $2.4 billion in cash.
Ono Pharma has offered $25.60 per share, a premium of 74.7% to the U.S. company's last closing price of $14.65.
Premarket trading of Deciphera's shares was currently halted.
The acquisition is expected to close in the third quarter of 2024, Deciphera said.
(Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 2,306 JPY | -0.90% | +0.57% | 6.99B | ||
| 25.44 USD | +0.08% | +0.24% | 2.2B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -8.33% | 6.99B | |
| +21.28% | 44.4B | |
| +24.60% | 23.03B | |
| +17.96% | 15.14B | |
| +12.87% | 13.12B | |
| +44.67% | 11.85B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.22% | 5.52B | |
| -6.31% | 4.62B |
ONO PHARMACEUTICAL CO., LTD. 
